Clinical Trial Update: Effects of Open-label vs Double-blind Treatment in IBS [NA]

View source ↗

Summary

A completed clinical trial comparing open-label versus double-blind treatment in irritable bowel syndrome, with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Irritable Bowel Syndrome, Placebo Effect | NA | Status: COMPLETED | Results posted: 2020-09-04